Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx
- Conditions
- Perioperative/Postoperative ComplicationsHead and Neck CancerPrecancerous Condition
- Interventions
- Procedure: assessment of therapy complicationsProcedure: diagnostic endoscopic surgeryProcedure: quality-of-life assessmentProcedure: therapeutic conventional surgeryProcedure: therapeutic endoscopic surgeryProcedure: transoral robotic surgeryProcedure: video-assisted surgery
- Registration Number
- NCT00918762
- Lead Sponsor
- Barbara Ann Karmanos Cancer Institute
- Brief Summary
RATIONALE: Transoral robotic surgery may make it easier to find and remove benign or malignant tumors of the larynx and pharynx and cause less damage to normal tissue. It is not yet known whether transoral robotic surgery is more effective than standard surgery in diagnosing and treating larynx and pharynx tumors.
PURPOSE: This phase I trial is studying how well transoral robotic surgery works compared with standard surgery in treating patients with benign or malignant tumors of the larynx or pharynx.
- Detailed Description
OBJECTIVES:
Primary
* Evaluate the potential benefits of using the transoral robotic surgical approach against the conventional open and transoral approaches in patients with benign or malignant disease involving the larynx and pharynx.
Secondary
* Determine the proportion of laryngeal and pharyngeal surgical procedures where the surgical exposure is adequate to allow the successful completion of the surgical resection using the transoral robotic surgical approach.
OUTLINE: Patients are assigned to transoral robotic surgery or standard therapy consisting of conventional transoral endoscopic or open approach according to their preference.
Patients undergo planned surgical procedures (either diagnostic or therapeutic) appropriate for their disease in the larynx or pharynx via the transoral robotic surgical approach or the conventional transoral endoscopic or open approach.
Patients complete the Functional Assessment of Cancer Therapy Head and Neck Scale, the Performance Status Scale for Head and Neck Cancer Patients, and the University of Washington Quality of Life Scale at baseline and at 3 and 6 months. Patients also undergo voice analysis by acoustic analyses, and speech and swallow pathology evaluation by videostroboscopy and modified barium swallow.
After completion of study procedure, patients are followed at 3 and 6 months.
PROJECTED ACCRUAL: A total of 80 patients will be accrued to the control group (standard conventional surgery) and 30 patients will be accrued to the robotic surgery group.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description daVinci® Robotic Surgical System therapeutic conventional surgery Participants will undergo a planned surgical procedures via the robotic approach. daVinci® Robotic Surgical System therapeutic endoscopic surgery Participants will undergo a planned surgical procedures via the robotic approach. daVinci® Robotic Surgical System assessment of therapy complications Participants will undergo a planned surgical procedures via the robotic approach. daVinci® Robotic Surgical System quality-of-life assessment Participants will undergo a planned surgical procedures via the robotic approach. daVinci® Robotic Surgical System diagnostic endoscopic surgery Participants will undergo a planned surgical procedures via the robotic approach. daVinci® Robotic Surgical System transoral robotic surgery Participants will undergo a planned surgical procedures via the robotic approach. daVinci® Robotic Surgical System video-assisted surgery Participants will undergo a planned surgical procedures via the robotic approach.
- Primary Outcome Measures
Name Time Method Operative time that directly affects operative cost post operative
- Secondary Outcome Measures
Name Time Method Need for reconstruction post operative Intra-operative and post-operative complications during the operation and post operative Margins status post operative Blood loss During surgery Length of hospital stay during time as inpatient Tracheostomy and PEG dependence post operative Days to oral intake post operative Speech intelligibility post operative Proportion of robotic surgical cases where adequate surgical exposure allowed for successful operation completion post operative Time to locoregional recurrence post operative Quality of life 3 months and 6 month following completion of surgery Postoperative pain post operative
Trial Locations
- Locations (1)
Barbara Ann Karmanos Cancer Institute
🇺🇸Detroit, Michigan, United States